Literature DB >> 24182529

Challenges in clinical trial design for HIV-1 cure research.

Nir Eyal1, Daniel R Kuritzkes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24182529     DOI： 10.1016/S0140-6736(13)62040-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  25 in total

Review 1.  Recent developments in clinical trial designs for HIV vaccine research.

Authors:  Laura Richert; Edouard Lhomme; Catherine Fagard; Yves Lévy; Geneviève Chêne; Rodolphe Thiébaut
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  The ethics of HIV "cure" research: what can we learn from consent forms?

Authors:  Gail E Henderson
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

3.  On Knowingly Setting Unrealistic Goals in Public Health.

Authors:  Nir Eyal; Manne Sjöstrand
Journal:  Am J Public Health       Date:  2020-02-20       Impact factor: 9.308

Review 4.  In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies.

Authors:  Christopher C Nixon; Maud Mavigner; Guido Silvestri; J Victor Garcia
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

5.  Research into a functional cure for HIV in neonates: the need for ethical foresight.

Authors:  Seema K Shah; Deborah Persaud; David S Wendler; Holly A Taylor; Hannah Gay; Mariana Kruger; Christine Grady
Journal:  Lancet Infect Dis       Date:  2014-06-04       Impact factor: 25.071

6.  Is it ethical to isolate study participants to prevent HIV transmission during trials with an analytical treatment interruption?

Authors:  Nir Eyal; Monica Magalhaes
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

7.  The potential of radioimmunotherapy as a new hope for HIV patients.

Authors:  Dina Tsukrov; Ekaterina Dadachova
Journal:  Expert Rev Clin Immunol       Date:  2014-05       Impact factor: 4.473

8.  "Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication.

Authors:  Ilona Fridman; Peter A Ubel; Jennifer Blumenthal-Barby; Cameron V England; Judith S Currier; Nir Eyal; Kenneth A Freedberg; Scott D Halpern; Colleen F Kelley; Daniel R Kuritzkes; Catherine N Le; Jeffrey L Lennox; Kathryn I Pollak; Brian J Zikmund-Fisher; Karen A Scherr
Journal:  AIDS Behav       Date:  2020-07

Review 9.  In vivo platforms for analysis of HIV persistence and eradication.

Authors:  J Victor Garcia
Journal:  J Clin Invest       Date:  2016-02-01       Impact factor: 14.808

10.  HIV Cure Research: Risks Patients Expressed Willingness to Accept.

Authors:  Allison Kratka; Peter A Ubel; Karen Scherr; Benjamin Murray; Nir Eyal; Christine Kirby; Madelaine N Katz; Lisa Holtzman; Kathryn Pollak; Kenneth Freedburg; Jennifer Blumenthal-Barby
Journal:  Ethics Hum Res       Date:  2019-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.